Wanglong Qiu
Overview
Explore the profile of Wanglong Qiu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
864
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheng H, Janakiram M, Borczuk A, Lin J, Qiu W, Liu H, et al.
Clin Cancer Res
. 2025 Feb;
31(4):788.
PMID: 39957403
No abstract available.
2.
Sellyei J, Yan X, Qiu W, Vasilescu E, Vlad G
HLA
. 2023 Oct;
103(1):e15237.
PMID: 37828799
We report a novel HLA-B*58 allele, now named B*58:141, identified by next-generation sequencing.
3.
Saeki K, Qiu W, Friedman R, Pan S, Lu J, Ichimiya S, et al.
Cancer Res Commun
. 2023 Mar;
2(12):1601-1616.
PMID: 36970723
Significance: We demonstrated that global inactivation of significantly improved the survival of an aggressive mouse model for PDAC and provided preclinical evidence that Notch4 and Pcsk5 are novel targets for...
4.
Fine R, Mao Y, Garcia-Carracedo D, Su G, Qiu W, Hochfeld U, et al.
Biomedicines
. 2023 Feb;
11(2).
PMID: 36830797
Any gene therapy for cancer will be predicated upon its selectivity against cancer cells and non-toxicity to normal cells. Therefore, safeguards are needed to prevent its activation in normal cells....
5.
Wang F, Liu Y, Qiu W, Shum E, Feng M, Zhao D, et al.
Cancer Res
. 2022 Jan;
82(7):1365-1379.
PMID: 35078819
Significance: These findings reveal the mechanistic function of METΔ14Ex alteration in driving metastasis and define novel metastasis-related pathways that could be targeted for more effective treatment of lung cancer with...
6.
Yan H, Yu C, Fine S, Youssof A, Yang Y, Yan J, et al.
Oncogene
. 2021 Oct;
40(50):6759-6771.
PMID: 34663879
Human pancreatic ductal adenocarcinoma (PDAC) harboring one KRAS mutant allele often displays increasing genomic loss of the remaining wild-type (WT) allele (known as LOH at KRAS) as tumors progress to...
7.
Qiu W, Kuo C, Tian Y, Su G
Biomedicines
. 2021 Aug;
9(7).
PMID: 34356885
Activin, a member of the TGF-β superfamily, is involved in many physiological processes, such as embryonic development and follicle development, as well as in multiple human diseases including cancer. Genetic...
8.
Garcia-Carracedo D, Cai Y, Qiu W, Saeki K, Friedman R, Lee A, et al.
Mol Cancer Res
. 2020 Mar;
18(6):822-834.
PMID: 32152233
The PI3K signaling pathway is frequently mutated in head and neck squamous cell carcinoma (HNSCC), often via gain-of-function (GOF) mutations in the gene. Here, we present novel genetically engineered mouse...
9.
Yan H, Qiu W, Koehne de Gonzalez A, Wei J, Tu M, Xi C, et al.
Cancer Lett
. 2018 Nov;
442:333-340.
PMID: 30447255
HHLA2 is a newly identified member of the B7 immune checkpoint family, but its function and crosstalk with immune cells is not fully understood. To gain insights into the HHLA2...
10.
Qiu W, Remotti H, Tang S, Wang E, Dobberteen L, Youssof A, et al.
Cancer Lett
. 2018 Mar;
423:71-79.
PMID: 29526803
PanINs and IPMNs are the two most common precursor lesions that can progress to invasive pancreatic ductal adenocarcinoma (PDA). DCLK1 has been identified as a biomarker of progenitor cells in...